MIMI HILDERLEY: Open Payments
NPI 1043905011 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 24 payments from 19 companies in 2025. Trend: 2023 $135 · 2024 $475 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $242 |
| KYOWA KIRIN, INC. | 1 | $126 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $59 |
| TerSera Therapeutics LLC | 2 | $57 |
| Daiichi Sankyo Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Exelixis Inc. | 1 | $29 |
| Menarini Silicon Biosystems, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: CRYSVITA, VOQUEZNA, Ozempic, Wegovy, Auvelity, Enhertu, CABOMETYX, Xermelo.
Industry payments across DE — which companies pay providers there.
